Staged PKD

Name of PI and Coordinator:
Simin Goral, MD, Debbie Grier, BSN, RN, MBA, CCRP
Contact:
Debbie Grier – debbra.grier@uphs.upenn.edu, 215-615-4938
Purpose of Study/Patient Population: Multicenter, randomized, double-blind, placebo-controlled two stage study to characterize the efficacy, safety, tolerability and pharmacokinetics of an investigational new drug in patients at risk of rapidly progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) The purpose is to determine the effect of an investigational new drug on rate of renal function (eGFR)decline as compared to placebo in patients at risk of rapidly progressive ADPKD. The study is divided into 2 stages.

Chronic Kidney Disease Dialysis Clinical Trials